DK1237866T3 - Amycomycin, en fremgangsmåde til dets fremstilling og dets anvendelse som et lægemiddel - Google Patents

Amycomycin, en fremgangsmåde til dets fremstilling og dets anvendelse som et lægemiddel

Info

Publication number
DK1237866T3
DK1237866T3 DK00983165T DK00983165T DK1237866T3 DK 1237866 T3 DK1237866 T3 DK 1237866T3 DK 00983165 T DK00983165 T DK 00983165T DK 00983165 T DK00983165 T DK 00983165T DK 1237866 T3 DK1237866 T3 DK 1237866T3
Authority
DK
Denmark
Prior art keywords
amycomycin
drug
preparation
stereoisomeric
dsm
Prior art date
Application number
DK00983165T
Other languages
English (en)
Inventor
Michael Kurz
Jozsef Aszodi
Cordula Hopmann
Heinrich Decker
Beller Dominique Le
Original Assignee
Aventis Pharma Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Gmbh filed Critical Aventis Pharma Gmbh
Application granted granted Critical
Publication of DK1237866T3 publication Critical patent/DK1237866T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/44—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having three double bonds between ring members or between ring members and non-ring members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
    • C12P17/10—Nitrogen as only ring hetero atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pyrrole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK00983165T 1999-12-08 2000-11-25 Amycomycin, en fremgangsmåde til dets fremstilling og dets anvendelse som et lægemiddel DK1237866T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99124456A EP1106604A1 (en) 1999-12-08 1999-12-08 Amycomycin, a process for its production and its use as a pharmaceutical
PCT/EP2000/011752 WO2001042210A1 (en) 1999-12-08 2000-11-25 Amycomycin, a process for its production and its use as a pharmaceutical

Publications (1)

Publication Number Publication Date
DK1237866T3 true DK1237866T3 (da) 2005-10-10

Family

ID=8239554

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00983165T DK1237866T3 (da) 1999-12-08 2000-11-25 Amycomycin, en fremgangsmåde til dets fremstilling og dets anvendelse som et lægemiddel

Country Status (28)

Country Link
US (1) US6642391B2 (da)
EP (2) EP1106604A1 (da)
JP (1) JP4750993B2 (da)
KR (1) KR100728514B1 (da)
CN (1) CN1217929C (da)
AT (1) ATE298744T1 (da)
AU (1) AU781398B2 (da)
BR (1) BR0016223A (da)
CA (1) CA2393518C (da)
CZ (1) CZ294370B6 (da)
DE (1) DE60021109T2 (da)
DK (1) DK1237866T3 (da)
EE (1) EE05219B1 (da)
ES (1) ES2243332T3 (da)
HK (1) HK1048998A1 (da)
HR (1) HRP20020497B1 (da)
HU (1) HU225194B1 (da)
IL (2) IL149904A0 (da)
ME (1) MEP28508A (da)
NO (1) NO322565B1 (da)
PL (1) PL201809B1 (da)
PT (1) PT1237866E (da)
RS (1) RS50288B (da)
RU (1) RU2261916C2 (da)
SI (1) SI1237866T1 (da)
SK (1) SK286776B6 (da)
WO (1) WO2001042210A1 (da)
ZA (1) ZA200204420B (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102417919B (zh) * 2011-09-02 2017-05-24 山东鲁抗医药股份有限公司 一种发酵法生产高纯度替考拉宁的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8700513D0 (en) * 1987-01-09 1987-02-11 Pfizer Ltd Antibiotics produced by fermentation
CA2016382A1 (en) * 1989-05-12 1990-11-12 Marvin M. Hoehn A59770 antibiotics
JPH05163289A (ja) * 1991-08-27 1993-06-29 Microbial Chem Res Found 新規な免疫抑制物質、ｍｉ７１０−５１ｆ６物質およびその製造法
JPH05286990A (ja) * 1992-04-08 1993-11-02 Meiji Seika Kaisha Ltd 新規マクロライド抗生物質および微生物変換を利用したマクロライド抗生物質の製造法
JP3107455B2 (ja) * 1992-05-08 2000-11-06 財団法人微生物化学研究会 新規抗生物質ｍｉ４８１−４２ｆ４−ａ及びその製造方法
JPH05317068A (ja) * 1992-05-14 1993-12-03 Kaiyo Bio Technol Kenkyusho:Kk 抗生物質マグネシジンの一成分の選択的製造法
JPH0733736A (ja) * 1993-07-26 1995-02-03 Microbial Chem Res Found 新規抗生物質アジセマイシンｂおよびその製造方法
JPH09157266A (ja) * 1995-12-04 1997-06-17 Microbial Chem Res Found 新規抗生物質エポキシキノマイシンａおよびｂとその製造法
EP0816539A1 (de) 1996-07-05 1998-01-07 Maschinenfabrik Rieter Ag Verfahren und Vorrichtung zur Produktionssteuerung an einer Karde
JPH1045738A (ja) * 1996-07-29 1998-02-17 Microbial Chem Res Found 抗生物質エポキシキノマイシンｃおよびｄとその製造法ならびに抗リウマチ剤
JPH10114777A (ja) * 1996-10-09 1998-05-06 Microbial Chem Res Found 抗生物質スピロキシマイシンとその製造法

Also Published As

Publication number Publication date
WO2001042210A1 (en) 2001-06-14
CZ294370B6 (cs) 2004-12-15
EP1237866B1 (en) 2005-06-29
CZ20021891A3 (cs) 2002-08-14
CN1217929C (zh) 2005-09-07
DE60021109T2 (de) 2006-05-04
HUP0203593A2 (hu) 2003-02-28
AU2001901A (en) 2001-06-18
YU13102A (sh) 2005-06-10
HUP0203593A3 (en) 2003-12-29
US20010018450A1 (en) 2001-08-30
RU2002118116A (ru) 2004-02-27
CA2393518C (en) 2009-01-20
HU225194B1 (en) 2006-08-28
NO322565B1 (no) 2006-10-23
SI1237866T1 (en) 2005-10-31
EE05219B1 (et) 2009-10-15
JP4750993B2 (ja) 2011-08-17
RU2261916C2 (ru) 2005-10-10
ZA200204420B (en) 2003-09-03
ME00182B (me) 2010-10-10
IL149904A (en) 2007-10-31
SK7872002A3 (en) 2002-11-06
SK286776B6 (sk) 2009-05-07
HRP20020497B1 (en) 2006-04-30
US6642391B2 (en) 2003-11-04
HK1048998A1 (en) 2003-04-25
CN1377341A (zh) 2002-10-30
ES2243332T3 (es) 2005-12-01
MEP28508A (en) 2010-10-10
IL149904A0 (en) 2002-11-10
NO20022654D0 (no) 2002-06-05
BR0016223A (pt) 2002-09-10
EE200200280A (et) 2003-06-16
CA2393518A1 (en) 2001-06-14
NO20022654L (no) 2002-06-05
AU781398B2 (en) 2005-05-19
DE60021109D1 (de) 2005-08-04
EP1237866A1 (en) 2002-09-11
HRP20020497A2 (en) 2004-08-31
PT1237866E (pt) 2005-10-31
PL201809B1 (pl) 2009-05-29
RS50288B (sr) 2009-09-08
KR20020063205A (ko) 2002-08-01
ATE298744T1 (de) 2005-07-15
PL355627A1 (en) 2004-05-04
KR100728514B1 (ko) 2007-06-15
JP2003516389A (ja) 2003-05-13
EP1106604A1 (en) 2001-06-13

Similar Documents

Publication Publication Date Title
AU1025795A (en) Prolineamide derivatives
NO20024772D0 (no) Percyquinnin, fremgangsmåte for dets fremstilling og dets anvendelse som et legemiddel
AU5636494A (en) N-heteroaryl-N'-phenylurea derivatives, their production and use
EP0388956A3 (en) Phthalinide derivative, pharmaceutical composition and use
FI101227B1 (fi) Menetelmä farmaseuttisesti aktiivisten 4-desoksi-4-epipodofyllotoksiinijohdannaisten valmistamiseksi
AU6220300A (en) Benzofurylpiperazine serotonin agonists
ATE100097T1 (de) Benzoxepin-derivate.
DK1237866T3 (da) Amycomycin, en fremgangsmåde til dets fremstilling og dets anvendelse som et lægemiddel
ATE165083T1 (de) N-arylalkylphenylacetamidderivate
DK0855398T3 (da) Sesquiterpenderivater med antiviral aktivitet
NO20013601L (no) Nye morfolinobenzamidsalter
DE69914880D1 (de) Substituierte 5-(2,2difluor-1,3-benzodioxol-5-yl) cyclopentenopyridinderivate
HUT75124A (en) Use of bicyclolactam derivatives for producing pharmaceutical compositions having anxiolytic activity
BG101996A (en) 9-n-ethylenederivatives of 9(s)-erythromycylamine
HU9803043D0 (en) Beta,beta-disubstituted derivatives of 9-deoxo-9a-n-ethenyl-9a-azo-9a-homoerythromycin-a
DK0412464T3 (da) Butalactin, en fremgangsmåde til dets fremstilling og dets anvendelse som lægemiddel